Kathleen E Bethin MD PhD
Pediatric Diabetes Endocrinology
Clinical Professor and Fellowship Program Director, Jacobs School of Medicine and Biomedical Sciences at University at Buffalo
Join to view full profile
1001 Main StFl 4Buffalo, NY 14203
Phone+1 716-323-0170
Fax+1 716-323-0297
Dr. Bethin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kathleen Bethin is a Pediatric Endocrinologist specializing in Pediatric Diabetes Endocrinology based in Buffalo, NY. She completed her fellowship in Pediatric Endocrinology and pediatrics residency at the Washington University/B-JH/SLCH Consortium and earned her medical degree in 1995 from the Jacobs School of Medicine at the University at Buffalo. She serves in multiple academic and clinical roles, including as Associate Chair for UBMD Outpatient Clinical Affairs and Clinical Professor at the same institution. Her research includes published works on pediatric diabetes, and she is involved in clinical trials related to Type 1 Diabetes and Central Precocious Puberty. Dr. Bethin has been recognized as one of America's Top Doctors from 2013 to 2020.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Endocrinology, 1997 - 2000- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1995 - 1997
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1995
Certifications & Licensure
NY State Medical License 2008 - 2027
American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly Medical Ltd., 2013-2020
Clinical Trials
- Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
- Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
- Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients Start of enrollment: 2017 Mar 27
Publications & Presentations
PubMed
- 2 citationsInhaled Technosphere Insulin in Children with Diabetes: The INHALE-1 Extension Study.Roy W Beck, Lauren Kanapka, Roshanak Monzavi, Steven M Willi, Michael Tansey
Diabetes Technology & Therapeutics. 2026-08-01 - Thyroid Monitoring After Intravascular Iodinated Contrast Media in Infants and Children Through 3 Years of Age.Ryan S Miller, Jonathan R Dillman, Matthew A Crystal, Kathleen Bethin, Catherine A Dinauer
Pediatrics. 2026-05-01 - 7 citationsINHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.Michael J Haller, Lauren Kanapka, Roshanak Monzavi, Thomas J Mouse, Gnanagurudasan Prakasam
Diabetes Care. 2026-01-01
Press Mentions
- Collaboration of UBMD Pediatrics and Cecelia Health to Help Children with Type 1 DiabetesApril 21st, 2022
University of Buffalo Investigators Contribute to the Global Trial Leading to the Approval of Fiasp®March 3rd, 2020- Physician Forum: Pediatricians Discuss Gender-Affirming Hormone TherapyApril 13th, 2024
Grant Support
- Genetic Analysis Of Myometrial Function In ParturitionEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2004
- Genetic Analysis Of Myometrial Function In ParturitionEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2003
External Links
- Women & Children's Hospital of Buffalohttp://www.wchob.org/ubmdpediatrics
- UBMD Pediatricshttp://ubmdpediatrics.com
- University at Buffalo Department of Pediatricshttp://medicine.buffalo.edu/pediatrics
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
